VC Fund Dossiers

360 Capital is one of Europe's most successful old-school VC shops that actually delivers results—their Preligens exit to Safran for €220M in 2024 and backing Exotec to become France's first industrial unicorn proves they know how to pick winners and get liquidity. Founded in 1997, they've survived multiple cycles and have the conviction to back deep tech when others chase software. Fausto Boni is a genuine operator with McKinsey pedigree who sits on boards and gets his hands dirty. The dual Paris-Milan setup gives them unique access to Southern European talent that coastal VCs miss. Their 71% seed to Series A conversion rate (92% including exits) is exceptional. Watch for their climate tech focus with the new €140M 360 LIFE II fund—they're betting big on energy transition when others just talk about it.

3VC is the disciplined European operator you want when the market gets frothy. While other funds were throwing money at inflated rounds in 2021, they stayed selective with their 3-4 deals per year strategy. This 'quality over quantity' approach paid off with 3 unicorns from just 12 Fund I companies - that's a 25% unicorn rate that would make Sequoia jealous. The team genuinely gets product-market fit (Eva's IoT background shows) and isn't afraid to get their hands dirty - they literally structured Gamee's acquisition by Animoca Brands during tough times. The downside? They're picky as hell and take forever to decide, plus their DACH/CEE focus means they might miss broader European trends.

This is the Rocket Internet alumni club rebranded for the deep tech era. The founding team - Kudlich from Rocket Internet/GFC, Ensthaler from GFC, and Leibert from Mesosphere - brings serious operational DNA and a track record of scaling tech companies. They've raised $1.3B across two funds since 2020, with Fund II closing at $400M. The good: they actually understand enterprise software and have skin in the game as former founders. They're betting big on MLOps and open source commercialization with investments in QuestDB, Iterative.ai, and ActivLoop. The watch-out: they have 3 unicorns (Razor Group, ClickUp, PandaDoc) but also some portfolio company exits that suggest they're not afraid to cut losses. They move fast and have strong conviction, but expect them to be hands-on - these aren't passive check-writers.

These guys are the anti-European VC stereotype—they actually write first checks into wild moonshots that European funds would pass on for being 'too early.' Both Oculus and Magic Pony were their first institutional money, which tells you everything about their conviction. They promise blunt feedback within 5 working days even on rejections, which founders love because you're not left hanging. The geopolitical 'free-world resilience' framing feels a bit performative, but their portfolio backs it up—they're genuinely betting on technologies that matter for Western competitiveness. They don't take board seats and see their value in the first 6-12 months helping you prep for the next round, so they're not going to micromanage you to death.

These guys have a refreshingly honest philosophy: they're not chasing unicorns, they're maximizing 'dragons' - companies that return the entire fund, and they've delivered at least one per fund generation. They've won Spain's Best VC Deal award three times in five years, which tells you they know how to pick and nurture winners. The founding team has serious technical chops - Alberto's MIT/Harvard, Nico's MIT/INSEAD with aerospace engineering background, and Rocío brings actual cybersecurity and trading software experience. Their exits speak volumes: AlienVault to AT&T, PlayGiga as the first Spanish startup acquired by Facebook, Seedtag to Advent International. They're obsessed with global scalability from day one - won't touch you unless you have a clear internationalization plan, because they know Spanish exits need global reach.

AlbionVC is the grown-up in the room of UK venture - they've been doing this since 1996 and it shows in their disciplined, thesis-driven approach. Their partners project an aura of patience and take a genuinely long-term view, with reputation and consistency carrying more weight than flashy deals. Founders consistently praise Ed Lascelles specifically - Tony Pepper from Egress called him "equally important" to their success alongside the team and tech, while Quantexa's CEO said they've been privileged to work with Ed and AlbionVC from the beginning. They actually stick around - Quantexa went from first investment in 2017 to a $175m Series F at $2.6bn valuation in 2025, with AlbionVC participating in every round. The downside? They're not going to move fast on trendy deals, and if you want VC theater or ego stroking, look elsewhere.

Aldea gets it - they're not trying to be heroes, they're smart money that understands the fund-of-funds game. Portfolio managers praise them for being "more than an investor - a true partner" who shows "real alignment" and "patience" with long deeptech timelines. They're playing the data game smartly, collecting intelligence on 1000+ companies to make better decisions while sharing anonymized insights with the ecosystem. The team has solid pedigree from established European funds, not Silicon Valley wannabes. They're also a certified B-Corp with a 95.3 impact score (median is 50.9), so they actually walk the sustainability talk. The concentration strategy in Fund II shows they're learning and getting pickier, which is what you want to see.

Amadeus is one of the rare VCs that actually walks the walk on deep tech—they've been at it since 1997 when most funds were still figuring out what the internet was. As one founder, whose startup ContactEngine was acquired by NICE Systems, put it, landing investment from Amadeus meant securing one of "the best VCs in our space." Hermann Hauser's track record speaks for itself (he basically created ARM), and Anne Glover has built this into a proper institution. They are active investors who commonly take board seats and provide strategic advice, recruitment support, and introductions to international networks and corporate partners. The firm prides itself on being supportive yet measured, understanding when to step back and let the founders steer their company. The exit track record is genuinely impressive—multiple billion-dollar outcomes across different cycles. But here's the rub: they're extremely technical and will grill you hard on IP and defensibility. founders should be prepared for rigorous technical due diligence from Amadeus's experienced partners, many of whom bring a deep scientific background themselves.

APEX Ventures is the rare European deep tech fund that actually understands what they're investing in - probably because their partners have real operational experience rather than just finance backgrounds. Andreas Riegler built and sold companies before becoming a VC, Wolfgang Neubert has deep technical expertise in photonics and quantum, and Gordon Euller is a practicing radiologist who worked at McKinsey. This translates into genuine value-add for founders wrestling with complex IP strategies and brutal commercialization timelines. The €80M Amadeus APEX Technology Fund partnership gives them serious firepower, and their portfolio companies consistently praise their hands-on support and network introductions. However, they're primarily focused on DACH region deals, so if you're not in Germany/Austria/Switzerland, you might be swimming upstream. Also, while they talk a good game about being 'founder-friendly,' deep tech investors by nature tend to want more control given the long development cycles and capital intensity.

Armilar is the real deal - they've backed three unicorns (OutSystems, Feedzai, Sword Health) and have genuine deep-tech credibility spanning 25+ years. Their track record of generating returns is grounded on backing founders throughout their journey, not just writing checks. However, they work on 16 percentage points less than the average amount of lead investments, meaning they're selective but might not always lead your round. The fact they successfully raised €120M in 2025's brutal fundraising environment speaks volumes about LP confidence in their returns. The senior team has been working together for a decade with 60+ years of cumulative VC experience - this isn't a new fund with untested dynamics.

Atlantic Bridge is the old guard of European tech - they've been doing cross-border deals since before it was cool. Brian Long and team have serious operator credentials (multiple IPOs, actual chip company exits) which matters when you're pitching deep tech. They're not just check-writers - they genuinely help European companies crack the US market through their Palo Alto office and connections. However, note that Atlantic Bridge gradually exited their entire position in Navitas stock in 2025 despite the company's strong showing that year - they know when to take profits. Their exit track record is legitimately impressive: Movidius to Intel, DecaWave to Qorvo, Blue Data to HPE, Hedvig to Commvault, NuVia to Qualcomm. They're particularly strong in semiconductors and enterprise software, but they move slowly and do serious due diligence.

Axon is that rare breed - a publicly traded VC (BME: APG) with €685 million AUM that actually knows what they're doing. With 1 unicorn (Forto), 7 IPOs, and 11 acquisitions in their portfolio, they've got the track record to back up the hype. The dual consulting-investment model is either genius or a distraction - it gives them deep sector insights but might split focus. Francisco Velazquez landing on the EU Innovation Council board shows they have serious Brussels connections, which matters for regulatory-heavy sectors. They're heavy on Spain/Southern Europe but expanding globally, so perfect if you're a Spanish startup needing local expertise and international ambitions. The climate tech push feels authentic given their track record, not just trend-chasing.

Here's the thing about b2venture - they're not your typical fund throwing money around hoping something sticks. Their 350+ angel investor community isn't just marketing fluff - it's their actual superpower, and founders consistently rave about the network effects. SumUp's founders literally said 'we'd always work with them again' and praised their ability to mobilize angels for later rounds. Track record speaks for itself: at least one unicorn per fund generation, 11 IPOs, 30+ trade sales. But here's what they won't tell you in their deck meetings - they're explicitly hunting for companies that can have 'very large exits' and short-term wins 'rarely move the needle' for them. So if you're building a lifestyle business or looking for a quick flip, look elsewhere. They want category-defining companies and have the patience to get there.

This is a fund with actual conviction and a thesis they live by - not just diversity theater. Their "migrants have more bite" philosophy isn't PC posturing; it's based on real pattern recognition. Portfolio wins like Faircado (Slush Top 100) and securing quality co-investors show they can pick and attract follow-on capital. The team has solid operator backgrounds, especially in Swiss/German markets where local networks matter. However, they're 3 percentage points less likely to achieve exits than peers - could be early-stage timing or deal selection. Their typical 350-500K CHF tickets are meaningful for pre-seed but not game-changing money.

Bayern Kapital operates as a co-investor alongside private investors, adhering to the pari-passu principle, and typically holds minority stakes. We invest according to the pari-passu principle. In the case of a financing round, this means that all parties involved are treated equally and must invest the same amount of capital as Bayern Kapital. This is both their strength and potential limitation - they're patient, government-backed capital that won't push for quick exits, but they require private lead investors to move. With 3 unicorns (IQM, Quantum Systems, EGYM) and strong exits like MorphoSys, they clearly pick winners, but their bureaucratic structure means slower decisions than pure private funds. Their 8-10 year investment horizons and €700M+ AUM make them ideal for deep tech that needs patient capital, but expect more process and committees than your typical VC.

Big Pi is the real deal in the Greek/diaspora space - they're not just tourist money but serious operators with legit exits under their belt (Accusonus to Meta for €70-100M). The team brings actual entrepreneurial chops: Marco built Upstream to €230M revenue, Nick was at Prime Ventures doing serious European deals, and Alex literally helped create the Python data science stack. They require portfolio companies to maintain substantial Greek operations, which is both a feature (cheap talent, government support) and potential bug (geographic constraint). Their "tech-first" mandate with IP requirements means they actually understand what defensible tech looks like, unlike funds that chase flashy B2C plays.

It's dubbed this approach 'high conviction investing'. 'Our philosophy is that we only succeed if the team succeeds; we're in it together,' she adds. Blossom walks the walk on founder support — they genuinely limit themselves to 5-6 deals per year so they can be ridiculously helpful. Unlike a typical lead Series A investor, Blossom generally doesn't take a board seat — it sits on boards for just two of its eight portfolio companies. Instead, Blossom builds dashboards with its portfolio companies, so that the team has live access to tracking metrics and data on the startups. They've cracked the code on being a true partner without being overbearing. The team has serious technical chops (Imran) plus strong US connections (Alex from IVP), and Ophelia's reputation for responsiveness is legendary. Their track record speaks volumes — Blossom Capital has a portfolio of 44 companies, including 6 unicorns. They're expensive (large Series A checks) but if you want a VC who genuinely rolls up sleeves and opens doors globally, they deliver.

BlueYard is what happens when former Earlybird partners decide to bet the farm on civilization ending or reaching utopia - and somehow nail the timing on both fronts. Their first fund's 76% gross IRR and 3.4x DPI speaks for itself, driven by getting into crypto in 2016, AI chips in 2018, and defense tech in 2023 when everyone else thought these spaces were radioactive. They're genuinely 'fluent in weirdness and volatility' - this isn't marketing speak. If you've been told you're 'too early, not big enough, or not in their category,' they literally want you to call them. The partners actually do deep technical diligence and aren't afraid to lead rounds in spaces that make other VCs uncomfortable. Fair warning: they're genuinely contrarian, so if you're building something obvious or looking for validation, this isn't your fund.

This is France's sovereign wealth fund playing VC - which means they have deeper pockets and longer patience than most, but also means they're not purely profit-driven. They offer unique convertible options that match private investment up to €250k with non-dilutive support, which founders love because it makes them more attractive to other investors. Their strategy is explicitly to create an 'entrepreneur friendly ecosystem' and develop France's VC industry to attract international money. The downside? Some French tech veterans like Ledger's co-founder argue that state backing has propped up fragile business models and created a 'perfusion economy' that masks underlying weaknesses. But founders consistently praise their operational involvement, strategic introductions, and commercial synergies that lead to 'decisive contracts.'

These guys are the rare VC fund that actually gets hardware and deep tech - not just buzzword deep tech, but real industrial engineering problems. According to their internal data, hardware and deep tech companies perform best because they focus on revenue early and have protectable IP almost right away. What's refreshing is they're hands-on without being micromanaging control freaks - they join each investment in 'sales and business development' sprints for a few weeks of heavy focus followed by reassessment. The founding partners complement each other well: Risku knows product-market fit from the operator side, Kanninen handles the complex deal structuring, and they're genuinely helpful post-investment rather than just board meeting attendees. The downside? They're geographically focused on the Nordics, so if you're not Finnish/Swedish or willing to relocate there, you're probably not on their radar.

This is Spain's establishment VC - they're the corporate venture arm of CriteriaCaixa, which manages over €25 billion and is backed by la Caixa Foundation. They've been around since 2007 and have made 300+ investments, so they know what they're doing, but they're also exactly what you'd expect from a big Spanish bank's VC arm. The good news: they have serious capital staying power, they actually stick around for follow-on rounds, and they exit 20% more often than average. The reality check: they're not exactly known for being the fastest movers or most founder-friendly when it comes to terms. New CEO Jordi Ros comes from 20 years of traditional corporate finance, not startup-land.

CIC has genuinely unique deal flow through their exclusive Cambridge University relationship - this isn't marketing fluff, they literally have privileged access to the best IP coming out of one of the world's top research universities. Their track record speaks for itself: Bicycle Therapeutics IPO on NASDAQ, CMR Surgical unicorn, Gyroscope sold to Novartis for $1.5B, plus solid exits like Inivata ($390M) and PetMedix ($285M). Williamson brings serious credibility - 20 years US VC experience and co-chaired the UK government's university spinout review, so he knows the ecosystem inside out. Their Entrepreneur in Residence program is actually working - they're co-founding companies like Immutrin (just raised £65M from Frazier Life Sciences) by pairing seasoned operators with Cambridge academics. The downside? You're essentially betting on Cambridge staying relevant in deep tech, and they're very UK-focused if you want Silicon Valley-style growth.

Capricorn is the rare European VC that actually walks the walk on deep tech and sustainability—they've been doing cleantech since 2007, way before it was cool again. With 2 unicorns (Electric Hydrogen and Xanadu) in their portfolio and a track record spanning 26 years, they're not just another generalist fund pretending to understand hard science. Jos Peeters is a proper physics PhD who's been in the game for over three decades and built the European VC infrastructure we know today. The team genuinely gets technical due diligence, but here's the catch: they're very Belgian in their approach—methodical, relationship-focused, and not flashy. They invest mostly in Belgium (28 companies) and Netherlands (9 companies), so if you're not in their geographic sweet spot or willing to relocate there, you might find yourself on the outside looking in.

This is classic old-school UK venture capital - the kind that's been around since 1999 and has the battle scars to prove it. They've delivered solid returns with 14 profitable exits since 2015 averaging 4.7x, including some standout wins like R2C Online at 12.6x and Accutronics at 9.1x. What's refreshing is they actually take board seats and get their hands dirty - each partner has direct portfolio responsibility and they're not afraid to help with hiring, customer introductions, and financial strategy. With £130m under management, they're mid-sized but experienced. The downside? They're a small team (2-10 employees) which means limited bandwidth, and their heavy life sciences focus means if you're not in healthcare/biotech, you're probably not their cup of tea. They seem genuinely committed to long-term value creation rather than quick flips, which is either exactly what you want or frustratingly slow depending on your timeline.

CDP is Italy's €4 billion sovereign wealth fund playing venture capitalist - which means you get the benefits of patient capital and government backing, but also all the bureaucracy that comes with it. They have an initial €1 billion to deploy and are making 40-50 investments per year, so they're not exactly selective. The real power here is Francesca Bria - she's the rare government appointee who actually gets technology and has street cred from transforming Barcelona's smart city approach. Under Resmini they grew from €230M to €4B AUM in 3 years, which is impressive scaling but raises questions about quality control. They're essentially the Italian government's attempt to bootstrap a venture ecosystem, so expect slower decision-making but also less pressure for quick exits since they're playing the long game for Italy's economic development.

Chalmers Ventures is the real deal for deeptech - they're not just investors throwing money around, they're basically the commercialization arm of one of Europe's top tech universities. Ranked as one of the world's top ten university-based venture builders, launching around ten new startups annually. The Google acquisition of Atlantic Quantum is proof they can get deeptech from lab to billion-dollar exits. What makes them different is the evergreen structure - they're not under pressure to return capital to LPs in 7-10 years, so they can actually wait for deeptech timelines. Pontus Ottosson has serious operational chops from his previous CEO role, not just investment experience. The downside? They're very focused on Chalmers ecosystem companies, so if you're not connected to the university, you're probably not getting a look.

Earlybird is one of Europe's genuine OG funds that's earned its stripes the hard way - they've been around since 1997 and have the exits to prove it. Their track record speaks volumes: early backer of UiPath (Europe's largest IPO ever), N26, and Aleph Alpha. What founders need to know is that this isn't just another check-writer - they genuinely get involved post-investment and have built serious operational expertise over 28 years. The recent restructuring shows they're not afraid to evolve and focus where they can add the most value. However, they're getting bigger and more institutionalized, which means longer decision cycles and more process than scrappy early-stage funds. They're also heavily Germanic in their approach - methodical, thorough, but sometimes slower to move than Silicon Valley-style funds.

Elaia is one of the rare European VCs that actually delivers on deep tech promises - they've built 3 unicorns (SandboxAQ, Shift Technology, Mirakl) and had legitimate exits like Criteo's $1.7B NASDAQ IPO and Teads' acquisition by Altice. Xavier Lazarus sits on boards and stays engaged post-investment, which founders consistently praise. The Lazard partnership (with minority stake and option to buy up to 100%) gives them serious growth capital firepower beyond typical VC constraints. However, one employee review noted they can lack operational character and become repetitive - potentially signaling they're better at picking winners than rolling up sleeves in the trenches. They're genuinely technical (math PhD founders) but watch for over-intellectualizing vs. practical market execution.

Fly is the anti-thesis fund that actually walks the walk. "If you are a deeply technical founder or working on a hard technical problem in Europe, your funding options at the inception stage mostly suck," stated Gabriel Matuschka. Founders often find it frustrating to simplify their pitches for investors who apply generic SaaS logic to everything. This approach can be harmful, especially in the early stages of deep tech development. These guys get in earlier than anyone else - Fly often engages with founders 6-9 months before they officially start their companies. The track record speaks for itself: Since Fly invested in Wayve's Seed Round in 2017, the company has raised a total in excess of USD 2B including its latest Series D at a USD 8.6B valuation and In September 2025, Check Point Software Technologies acquired Lakera for USD 300M. The catch? They're genuinely technical gatekeepers - Many early stage funds will say it's all about the team, but we like to think we keep a higher bar than most. If you can't geek out about your tech stack with Fredrik or convince Gabriel why your "impossible" problem is actually solvable, you're not getting in. But if you do make it through, Over 75 per cent of Fly's portfolio companies go on to raise a follow-on round or get acquired vs. the industry average of 31 per cent for Seed VCs in Europe.